OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Brain Derived Neurotrophic Factor and Cognitive Dysfunction in the Schizophrenia-Bipolar Spectrum: A Systematic Review and Meta-Analysis
Z.B. Dombi, István Szendi, Philip W. J. Burnet
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 13
Z.B. Dombi, István Szendi, Philip W. J. Burnet
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 13
Showing 13 citing articles:
Brain-derived neurotrophic factor levels across psychiatric disorders: A systemic review and network meta-analysis
Yazhu Zou, Yuan Zhang, Mengtian Tu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110954-110954
Closed Access | Times Cited: 22
Yazhu Zou, Yuan Zhang, Mengtian Tu, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 131, pp. 110954-110954
Closed Access | Times Cited: 22
Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
Anton Shkundin, Angelos Halaris
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1395-1395
Open Access | Times Cited: 24
Anton Shkundin, Angelos Halaris
Journal of Personalized Medicine (2023) Vol. 13, Iss. 9, pp. 1395-1395
Open Access | Times Cited: 24
Electrochemical sensor based on molecularly imprinted polymer for rapid quantitative detection of brain-derived neurotrophic factor
Akinrinade George Ayankojo, Roman Boroznjak, Jekaterina Reut, et al.
Sensors and Actuators B Chemical (2023) Vol. 397, pp. 134656-134656
Closed Access | Times Cited: 12
Akinrinade George Ayankojo, Roman Boroznjak, Jekaterina Reut, et al.
Sensors and Actuators B Chemical (2023) Vol. 397, pp. 134656-134656
Closed Access | Times Cited: 12
Neuroglia in mood disorders
Gijsje J. L. Snijders, Frederieke Gigase
Handbook of clinical neurology (2025), pp. 287-302
Closed Access
Gijsje J. L. Snijders, Frederieke Gigase
Handbook of clinical neurology (2025), pp. 287-302
Closed Access
Changes in BDNF methylation patterns after cognitive remediation therapy in schizophrenia: A randomized and controlled trial
Rafael Penadés, Carmen Almodóvar-Payá, Clemente García-Rizo, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 166-174
Closed Access | Times Cited: 3
Rafael Penadés, Carmen Almodóvar-Payá, Clemente García-Rizo, et al.
Journal of Psychiatric Research (2024) Vol. 173, pp. 166-174
Closed Access | Times Cited: 3
Converging Evidence Points to BDNF as Biomarker of Depressive Symptoms in Schizophrenia-Spectrum Disorders
Mirko Manchia, Ulker Isayeva, Roberto Collu, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 15
Mirko Manchia, Ulker Isayeva, Roberto Collu, et al.
Brain Sciences (2022) Vol. 12, Iss. 12, pp. 1666-1666
Open Access | Times Cited: 15
Brain-Derived Neurotrophic Factor (BDNF) as a Predictor of Treatment Response in Schizophrenia and Bipolar Disorder: A Systematic Review
Andrés Liberona, Natalia R. Jones, Karen Zúñiga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11204-11204
Open Access | Times Cited: 2
Andrés Liberona, Natalia R. Jones, Karen Zúñiga, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11204-11204
Open Access | Times Cited: 2
Enhanced Detection of Brain-Derived Neurotrophic Factor (BDNF) Using a Reduced Graphene Oxide Field-Effect Transistor Aptasensor
Mostafa Salehirozveh, Robin Bonné, Peeyush Kumar, et al.
Nanoscale (2024)
Open Access | Times Cited: 1
Mostafa Salehirozveh, Robin Bonné, Peeyush Kumar, et al.
Nanoscale (2024)
Open Access | Times Cited: 1
Strategies for Achieving Better Cognitive Health in Individuals with Schizophrenia Spectrum: A Focus on the Canadian Landscape: Stratégies pour atteindre une meilleure santé cognitive chez les personnes souffrant du spectre de la schizophrénie : un regard sur le paysage canadien
Martín Lepage, Synthia Guimond, Thomas J. Raedler, et al.
The Canadian Journal of Psychiatry (2024)
Closed Access
Martín Lepage, Synthia Guimond, Thomas J. Raedler, et al.
The Canadian Journal of Psychiatry (2024)
Closed Access
Fecal Microbiota Underlying the Coexistence of Schizophrenia and Multiple Sclerosis in Chinese Patients
Li Shao, Jinlong Fu, Lulu Xie, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 1
Li Shao, Jinlong Fu, Lulu Xie, et al.
Canadian Journal of Infectious Diseases and Medical Microbiology (2023) Vol. 2023, pp. 1-10
Open Access | Times Cited: 1
Нейропластичность мозга: мозговой нейротрофический фактор и протеинкиназные сигнальные пути
Е.В. Михалицкая, Л.А. Левчук
Сибирский вестник психиатрии и наркологии (2022), Iss. 3(116)
Open Access | Times Cited: 2
Е.В. Михалицкая, Л.А. Левчук
Сибирский вестник психиатрии и наркологии (2022), Iss. 3(116)
Open Access | Times Cited: 2
Differences in Muscle Strength, Physical Activity, and Cardiometabolic Risk Factors between Type 2 Diabetic Patients with and Without Benzodiazepines or Antipsychotic Medications
Hidetaka Hamasaki
Heart and Mind (2022) Vol. 6, Iss. 3, pp. 167-172
Open Access | Times Cited: 2
Hidetaka Hamasaki
Heart and Mind (2022) Vol. 6, Iss. 3, pp. 167-172
Open Access | Times Cited: 2
